About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered, the Centers for Disease Control and Prevention said in a statement.
Category: Washington Post
Didn’t drive very much in the pandemic? Be sure to tune up your skills as well as your car.
“Don’t get behind the wheel and think it’s suddenly going to all come back to you,” traffic expert says. Follow these tips on vehicle checkups, driving safety and health needs.
Volunteering in nursing homes gives teens experience and career inspiration
Senior living system offer teens from 10 underserved schools the chance to volunteer and get free training for entry-level health jobs and career coaching.
Calming computer jitters: Help for the elderly who aren’t tech-savvy
Government agencies, nonprofit groups and other organizations offer help in digital literacy for older adults during the pandemic.
Pfizer expected to brief U.S. officials in coming days on the need for a booster shot
Top U.S. health officials have not decided whether boosters will be necessary.
The Big Number: 12 out of 200 types of mosquitoes spread diseases in the U.S.
West Nile, Zika, dengue and malaria are among the illnesses that some of these insects can carry. But there are ways to stem the spread of mosquito-borne diseases.
How our emotional lives improve with age
As people grow older, they gain greater control of their feelings. How do they do that — and can they teach young people a thing or two?
‘Speaking of Psychology,’ an award-winning podcast, explores new research and discoveries into how we think and behave
The series covers all sorts of interesting topics, such as violence, technology, sexuality and even shyness.
FDA head urges probe of agency’s dealings with Biogen, maker of controversial new Alzheimer’s drug
The approval of Aduhelm set off a firestorm, with critics saying the medication doesn’t work and accusing the agency of getting too close to the company.
Pfizer suggests booster shots will be needed this year, but government officials say science will dictate the timing
Pfizer announced it would seek authorization of a booster shot within weeks, but the FDA and CDC said it was unclear when boosters would be needed.
